Fig. 2 | Scientific Data

Fig. 2

From: Interactome dynamics of RAF1-BRAF kinase monomers and dimers

Fig. 2

Principal Component Analysis (PCA) showing the effects of each condition on sample separation. (A) Separation by Vemurafenib and Sorafenib treatments. Control, transfection with V5-FRB and Flag-FKBP; DMSO, vehicle control. (B) Separation by dimerization. A/C, samples treated with A/C dimerizer drug; samples treated with DMSO. (C) Effects of expression of BRAF vs. BRAFV600E.

Back to article page